Hemolytic uremic syndrome induced by infusion of oxaliplatin: a case report.
Tumori
; 97(5): 31e-3e, 2011.
Article
em En
| MEDLINE
| ID: mdl-22158507
ABSTRACT
INTRODUCTION:
Oxaliplatin is a third-generation platinum compound with proven antitumor activity in the treatment of colorectal cancer. The occurrence of life-threating hemolitic uremic syndrome has been observed after oxaliplatin therapy. The kind of tumor and treatment modalities seem to influence the onset of hemolitic uremic syndrome.METHODS:
The clinical course of the case is reviewed and compared with reports of other similar cases in the literature.RESULTS:
We describe the development of hemolitic uremic syndrome as a result of prolonged oxaliplatin treatment of a colon cancer patient.CONCLUSIONS:
Although this rare event requires the concurrence of other unknown factors, it should be considered in a decision-making setting.
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
6_ODS3_enfermedades_notrasmisibles
Base de dados:
MEDLINE
Assunto principal:
Compostos Organoplatínicos
/
Neoplasias Colorretais
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Síndrome Hemolítico-Urêmica
Tipo de estudo:
Prognostic_studies
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Tumori
Ano de publicação:
2011
Tipo de documento:
Article